OncoType Dx: Predicting Cancer Recurrence

This article has been moved to a new location
View article

ASCO: Gene Assay Predicts Colon Cancer Recurrence

Feb 28, 2015 - In patients with stage II colon cancer, a new genomic test -- the Oncotype DX colon assay -- can accurately predict the risk of recurrence, according to research to be presented May 30 at the annual meeting of the American Society of Clinical Oncology, held from May 29 to June 2 in Orlando, Fla.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More